There were 338 germline BRCA mutation carriers in the POSH study breast cancer cohort; focality data were missing in 37 cases, leaving 180 women with a BRCA1 mutation and 121 with a BRCA2 mutation for analysis. The gene discussed is BRCA1; the disease is breast carcinoma.